Charged and hydrophobic surfaces on the a chain of Shiga-Like toxin 1 recognize the C-Terminal domain of ribosomal stalk proteins

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  McCluskey, Andrew J ^a   Bolewska Pedyczak, Eleonora ^b   Jarvik, Nick ^c   Chen, Gang ^c   Sidhu, Sachdev S ^c   Gariépy, Jean ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; PROTEIN VARIANT; RIBOSOMAL STALK PROTEIN; RIBOSOME PROTEIN; RNA; SCAFFOLD PROTEIN; SERINE; TETRAPEPTIDE; TRIPEPTIDE; UNCLASSIFIED DRUG; VEROTOXIN 1; OLIGOPEPTIDE; RECOMBINANT PROTEIN; RIBOSOME RNA;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; DISSOCIATION CONSTANT; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR RECOGNITION; MUTAGENESIS; MUTATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TERTIARY STRUCTURE; STATIC ELECTRICITY; SURFACE PLASMON RESONANCE; TWO HYBRID SYSTEM; YEAST; CHEMICAL PHENOMENA; DRUG ANTAGONISM; ENZYME ACTIVE SITE; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN SYNTHESIS; RIBOSOME; SEQUENCE HOMOLOGY;

EUKARYOTA;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RIBOSOMAL PROTEINS; RIBOSOMES; RNA, RIBOSOMAL; SEQUENCE HOMOLOGY, AMINO ACID; SHIGA TOXIN 1; SURFACE PLASMON RESONANCE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84857098126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031191     Document Type: Article

References (60)

1. Karmali MA, (1989) Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2: 15-38.
2. Riley LW, (1987) The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu Rev Microbiol 41: 383-407.
3. Fraser ME, Chernaia MM, Kozlov YV, James MN, (1994) Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat Struct Biol 1: 59-64.
4. Kozlov YV, Chernaia MM, Fraser ME, James MN, (1993) Purification and crystallization of Shiga toxin from Shigella dysenteriae. J Mol Biol 232: 704-706.
5. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE, et al. (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262: 1779-1785.
6. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, et al. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262: 8834-8839.
7. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT, (1986) Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163: 1391-1404.
8. Johannes L, Goud B, (1998) Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol 8: 158-162.
9. Garred O, van Deurs B, Sandvig K, (1995) Furin-induced cleavage and activation of Shiga toxin. J Biol Chem 270: 10817-10821.
10. Lea N, Lord JM, Roberts LM, (1999) Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157:H7 Shiga-like toxin-1. Microbiology 145 (Pt 5): 999-1004.
11. LaPointe P, Wei X, Gariepy J, (2005) A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J Biol Chem 280: 23310-23318.
12. Brigotti M, Carnicelli D, Alvergna P, Mazzaracchio R, Sperti S, et al. (1997) The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin. Toxicon 35: 1431-1437.
13. Endo Y, Mitsui K, Motizuki M, Tsurugi K, (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262: 5908-5912.
14. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, et al. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 45-50.
15. McCluskey AJ, Poon GM, Bolewska-Pedyczak E, Srikumar T, Jeram SM, et al. (2008) The catalytic subunit of shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain. J Mol Biol 378: 375-386.
16. Moazed D, Robertson JM, Noller HF, (1988) Interaction of elongation factors EF-G and EF-Tu with a conserved loop in 23S RNA. Nature 334: 362-364.
17. Hausner TP, Atmadja J, Nierhaus KH, (1987) Evidence that the G2661 region of 23S rRNA is located at the ribosomal binding sites of both elongation factors. Biochimie 69: 911-923.
18. Montanaro L, Sperti S, Mattioli A, Testoni G, Stirpe F, (1975) Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomes. Biochem J 146: 127-131.
19. Endo Y, Tsurugi K, (1988) The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 263: 8735-8739.
20. Chiou JC, Li XP, Remacha M, Ballesta JP, Tumer NE, (2008) The ribosomal stalk is required for ribosome binding, depurination of the rRNA and cytotoxicity of ricin A chain in Saccharomyces cerevisiae. Mol Microbiol 70: 1441-1452.
21. Li XP, Grela P, Krokowski D, Tchorzewski M, Tumer NE, (2010) Pentameric organization of the ribosomal stalk accelerates recruitment of ricin a chain to the ribosome for depurination. J Biol Chem 285: 41463-41471.
22. Chan DS, Chu LO, Lee KM, Too PH, Ma KW, et al. (2007) Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses. Nucleic Acids Res 35: 1660-1672.
23. Chan SH, Hung FS, Chan DS, Shaw PC, (2001) Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B. Eur J Biochem 268: 2107-2112.
24. Bargis-Surgey P, Lavergne JP, Gonzalo P, Vard C, Filhol-Cochet O, et al. (1999) Interaction of elongation factor eEF-2 with ribosomal P proteins. Eur J Biochem 262: 606-611.
25. Datta PP, Sharma MR, Qi L, Frank J, Agrawal RK, (2005) Interaction of the G′ domain of elongation factor G and the C-terminal domain of ribosomal protein L7/L12 during translocation as revealed by cryo-EM. Mol Cell 20: 723-731.
26. Helgstrand M, Mandava CS, Mulder FA, Liljas A, Sanyal S, et al. (2007) The ribosomal stalk binds to translation factors IF2, EF-Tu, EF-G and RF3 via a conserved region of the L12 C-terminal domain. J Mol Biol 365: 468-479.
27. Grela P, Helgstrand M, Krokowski D, Boguszewska A, Svergun D, et al. (2007) Structural characterization of the ribosomal P1A-P2B protein dimer by small-angle X-ray scattering and NMR spectroscopy. Biochemistry 46: 1988-1998.
28. Tchorzewski M, Krokowski D, Boguszewska A, Liljas A, Grankowski N, (2003) Structural characterization of yeast acidic ribosomal P proteins forming the P1A-P2B heterocomplex. Biochemistry 42: 3399-3408.
29. Naganuma T, Shiogama K, Uchiumi T, (2007) The N-terminal regions of eukaryotic acidic phosphoproteins P1 and P2 are crucial for heterodimerization and assembly into the ribosomal GTPase-associated center. Genes Cells 12: 501-510.
30. Krokowski D, Boguszewska A, Abramczyk D, Liljas A, Tchorzewski M, et al. (2006) Yeast ribosomal P0 protein has two separate binding sites for P1/P2 proteins. Mol Microbiol 60: 386-400.
31. Perez-Fernandez J, Remacha M, Ballesta JP, (2005) The acidic protein binding site is partially hidden in the free Saccharomyces cerevisiae ribosomal stalk protein P0. Biochemistry 44: 5532-5540.
32. Hagiya A, Naganuma T, Maki Y, Ohta J, Tohkairin Y, et al. (2005) A mode of assembly of P0, P1, and P2 proteins at the GTPase-associated center in animal ribosome: in vitro analyses with P0 truncation mutants. J Biol Chem 280: 39193-39199.
33. Gonzalo P, Lavergne JP, Reboud JP, (2001) Pivotal role of the P1 N-terminal domain in the assembly of the mammalian ribosomal stalk and in the proteosynthetic activity. J Biol Chem 276: 19762-19769.
34. Santos C, Ballesta JP, (2005) Characterization of the 26S rRNA-binding domain in Saccharomyces cerevisiae ribosomal stalk phosphoprotein P0. Mol Microbiol 58: 217-226.
35. Yamasaki S, Furutani M, Ito K, Igarashi K, Nishibuchi M, et al. (1991) Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. Microb Pathog 11: 1-9.
36. Hovde CJ, Calderwood SB, Mekalanos JJ, Collier RJ, (1988) Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci U S A 85: 2568-2572.
37. Fields S, Song O, (1989) A novel genetic system to detect protein-protein interactions. Nature 340: 245-246.
38. Bravman T, Bronner V, Lavie K, Notcovich A, Papalia GA, et al. (2006) Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem 358: 281-288.
39. Li XP, Chiou JC, Remacha M, Ballesta JP, Tumer NE, (2009) A two-step binding model proposed for the electrostatic interactions of ricin a chain with ribosomes. Biochemistry 48: 3853-3863.
40. Qin S, Zhou HX, (2009) Dissection of the high rate constant for the binding of a ribotoxin to the ribosome. Proc Natl Acad Sci U S A 106: 6974-6979.
41. Korennykh AV, Correll CC, Piccirilli JA, (2007) Evidence for the importance of electrostatics in the function of two distinct families of ribosome inactivating toxins. Rna 13: 1391-1396.
42. Sturm MB, Schramm VL, (2009) Detecting ricin: sensitive luminescent assay for ricin A-chain ribosome depurination kinetics. Anal Chem 81: 2847-2853.
43. Endo Y, Tsurugi K, (1988) The RNA N-glycosidase activity of ricin A-chain. Nucleic Acids Symp Ser pp. 139-142.
44. Tam PJ, Lingwood CA, (2007) Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 153: 2700-2710.
45. Hazes B, Read RJ, (1997) Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36: 11051-11054.
46. Korennykh AV, Piccirilli JA, Correll CC, (2006) The electrostatic character of the ribosomal surface enables extraordinarily rapid target location by ribotoxins. Nat Struct Mol Biol 13: 436-443.
47. Too PH, Ma MK, Mak AN, Wong YT, Tung CK, et al. (2009) The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome. Nucleic Acids Res 37: 602-610.
48. Yang Y, Mak AN, Shaw PC, Sze KH, (2010) Solution structure of an active mutant of maize ribosome-inactivating protein (MOD) and its interaction with the ribosomal stalk protein P2. J Mol Biol 395: 897-907.
49. Di R, Kyu E, Shete V, Saidasan H, Kahn PC, et al. (2011) Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae. Toxicon 57: 525-539.
50. Noris M, Remuzzi G, (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16: 1035-1050.
51. Jackson MP, Neill RJ, O'Brien AD, Holmes RK, Newland JW, (1987) Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. J FEMS Microbiology Letters 44: 109-114.
52. Ayub MJ, Smulski CR, Ma KW, Levin MJ, Shaw PC, et al. (2008) The C-terminal end of P proteins mediates ribosome inactivation by trichosanthin but does not affect the pokeweed antiviral protein activity. Biochem Biophys Res Commun 369: 314-319.
53. Frank C, Werber D, Cramer JP, Askar M, Faber M, et al. (2011) Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany- Preliminary Report. N Engl J Med.
54. Kupferschmidt K, (2011) Infectious diseases. As E. coli outbreak recedes, new questions come to the fore. Science 333: 27.
55. Voelker R, (2011) Rare E. coli strain races through Europe; high rate of kidney failure reported. Jama 306: 29.
56. Bai Y, Watt B, Wahome PG, Mantis NJ, Robertus JD, (2010) Identification of new classes of ricin toxin inhibitors by virtual screening. Toxicon 56: 526-534.
57. Pang YP, Park JG, Wang S, Vummenthala A, Mishra RK, et al. (2011) Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach. PLoS One 6: e17883.
58. Roxas-Duncan V, Enyedy I, Montgomery VA, Eccard VS, Carrington MA, et al. (2009) Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A. Antimicrob Agents Chemother 53: 3478-3486.
59. Tchorzewski M, Boldyreff B, Issinger O, Grankowski N, (2000) Analysis of the protein-protein interactions between the human acidic ribosomal P-proteins: evaluation by the two hybrid system. Int J Biochem Cell Biol 32: 737-746.
60. McCluskey AJ, Poon GM, Gariepy J, (2007) A rapid and universal tandem-purification strategy for recombinant proteins. Protein Sci 16: 2726-2732.